Home > Press > MIT-Harvard CCNE Collaborator Awarded with Nobel Prize in Medicine
Abstract:
This year's Nobel Prize in Medicine was awarded to three scientists — Drs. Jack W. Szostak, Elizabeth H. Blackburn and Carol W. Greider. The laureates have solved a major problem in biology: how the chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation. The Nobel Laureates have shown that the solution is to be found in the ends of the chromosomes — the telomeres — and in an enzyme that forms them — telomerase.
Dr. Szostak has ties to the NCI Alliance for Nanotechnology in Cancer through collaborations with Drs. Omid Farokhzad and Robert Langer at MIT-Harvard and the project dedicated to "Targeted Polymeric Nanoparticles for Cancer Therapeutic Applications". The goal of this project is to develop targeted polymeric nanoparticles for in vivo targeted delivery of cytotoxic, drug-encapsulated, controlled-release to cancer cells. This novel approach allows for a large amount of drug to be delivered to cancer cells and make it possible to reach a steady state cytotoxic drug concentration at the tumor site over an extended period of time. Dr. Szostak who is also a pioneer of aptamer technology has been involved in designing and optimizing the use of these novel classes of molecules for cancer therapy in support of CCNE project.
Learn more about the MIT-Harvard Center of Cancer Nanotechnology Excellence, here: nano.cancer.gov/action/programs/mit/
Read more about the 2009 Nobel Prize in Medicine winners, here: nobelprize.org/nobel_prizes/medicine/laureates/2009/index.html
####
About NCI Alliance for Nanotechnology in Cancer
The NCI Alliance for Nanotechnology in Cancer is catalyzing targeted discovery and development efforts that offer the greatest advances in the near and medium terms and to lower the barriers for those advances to be handed off to the private sector for commercial development.
For more information, please click here
Contacts:
NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A52
31 Center Drive, MSC 2580
Bethesda, MD 20892-2580
Telephone: (301) 496-1550
Copyright © NCI Alliance for Nanotechnology in Cancer
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
Govt.-Legislation/Regulation/Funding/Policy
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
Optically trapped quantum droplets of light can bind together to form macroscopic complexes March 8th, 2024
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Nanobiotechnology
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||